Effects of tirzepatide on brain dopaminergic function in alcohol use disorder: protocol for a randomized, double-blind, crossover PET/MRI study
Alcohol use disorder (AUD) is a leading cause of preventable morbidity and mortality, yet currently approved pharmacotherapies have only modest efficacy. Emerging preclinical, clinical, and pharmacoepidemiologic evidence suggests that glucagon-like peptide-1 (GLP-1) receptor agonists may reduce alcohol consumptio...